NO20081942L - Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser - Google Patents

Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser

Info

Publication number
NO20081942L
NO20081942L NO20081942A NO20081942A NO20081942L NO 20081942 L NO20081942 L NO 20081942L NO 20081942 A NO20081942 A NO 20081942A NO 20081942 A NO20081942 A NO 20081942A NO 20081942 L NO20081942 L NO 20081942L
Authority
NO
Norway
Prior art keywords
phospholipases
lipases
inhibitors
carbamoylbenzotriazole
derivatives
Prior art date
Application number
NO20081942A
Other languages
English (en)
Norwegian (no)
Inventor
Gerhard Zoller
Stefan Petry
Gunter Muller
Norbert Tennagels
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20081942L publication Critical patent/NO20081942L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18—Benzotriazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Enzymes And Modification Thereof (AREA)
NO20081942A 2005-10-19 2008-04-23 Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser NO20081942L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005049953A DE102005049953A1 (de) 2005-10-19 2005-10-19 Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen
PCT/EP2006/009857 WO2007045393A1 (fr) 2005-10-19 2006-10-12 Derives de carbamoyle-benzotriazol utilises comme inhibiteurs de lipases et de phospholipases

Publications (1)

Publication Number Publication Date
NO20081942L true NO20081942L (no) 2008-04-23

Family

ID=37667178

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081942A NO20081942L (no) 2005-10-19 2008-04-23 Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser

Country Status (26)

Country Link
US (2) US7897625B2 (fr)
EP (1) EP1940807B1 (fr)
JP (1) JP2009512650A (fr)
KR (1) KR20080063474A (fr)
CN (1) CN101291918A (fr)
AR (1) AR057554A1 (fr)
AU (1) AU2006303552A1 (fr)
BR (1) BRPI0617613A2 (fr)
CA (1) CA2625722A1 (fr)
CR (1) CR9850A (fr)
DE (1) DE102005049953A1 (fr)
DO (1) DOP2006000226A (fr)
EC (1) ECSP088377A (fr)
GT (1) GT200600463A (fr)
HN (1) HN2006035238A (fr)
IL (1) IL190714A0 (fr)
MA (1) MA29858B1 (fr)
NO (1) NO20081942L (fr)
NZ (1) NZ567573A (fr)
PE (1) PE20070724A1 (fr)
RU (1) RU2430096C2 (fr)
TN (1) TNSN08177A1 (fr)
TW (1) TW200730513A (fr)
UY (1) UY29872A1 (fr)
WO (1) WO2007045393A1 (fr)
ZA (1) ZA200802370B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007305269A1 (en) * 2006-10-04 2008-04-10 Schering Corporation Bicyclic and tricyclic derivatives as thrombin receptor antagonists
EP2025674A1 (fr) 2007-08-15 2009-02-18 sanofi-aventis Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament
WO2010003624A2 (fr) 2008-07-09 2010-01-14 Sanofi-Aventis Composés hétérocycliques, leurs procédés de préparation, médicaments comprenant lesdits composés et leur utilisation
EP2351744B1 (fr) * 2008-10-17 2015-01-07 Shionogi & Co., Ltd. Dérivé amide d'acide acétique ayant une activité inhibitrice d'une lipase endothéliale vasculaire
TWI469979B (zh) * 2008-12-24 2015-01-21 Bial Portela & Ca Sa 脂肪酸醯胺水解酶(faah)抑制劑、以及其藥學組成物與用途
EP2470527A4 (fr) * 2009-08-20 2013-02-27 Merck Sharp & Dohme Dérivés d éther de benzotriazole
CA2784710A1 (fr) 2009-12-15 2011-06-23 Shionogi & Co., Ltd. Derive d'oxadiazole ayant une activite d'inhibition de la lipase endotheliale
US8450350B2 (en) * 2010-05-05 2013-05-28 Infinity Pharmaceuticals, Inc. Triazoles as inhibitors of fatty acid synthase
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
CA2812593A1 (fr) * 2010-09-27 2012-04-12 Janssen Pharmaceutica Nv Derives alpha-cetoamide utiles comme inhibiteurs de lipase endotheliale
HUE042032T2 (hu) 2013-02-25 2019-06-28 Aurigene Discovery Tech Ltd Triszubsztituált benzotriazol-származékok, melyek dihidro-orotát-oxigenáz-inhibitor hatásúak
RU2563254C2 (ru) * 2013-07-08 2015-09-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Способ получения производных 7-(гетеро)арил-4,5,6,7-тетрагидро[1,2,3]триазоло[1,5-a]пиридина
RU2553987C1 (ru) * 2013-12-26 2015-06-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный университет" (СПбГУ) N-адамантилбензотриазолы, проявляющие активность против вируса гриппа а, и способ их получения
CN104292172B (zh) * 2014-09-12 2016-08-17 浙江理工大学 一种苯并三氮唑类衍生物及其制备方法
US20180369206A1 (en) 2017-04-24 2018-12-27 Aurigene Discovery Technologies Limited Methods of Use for Trisubstituted Benzotriazole Derivatives as Dihydroorotate Oxygenase Inhibitors
IL270066B2 (en) 2017-04-24 2023-10-01 Aurigene Oncology Ltd Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors
KR102861339B1 (ko) 2018-02-20 2025-09-19 르 라보레또레 쎄르비에르 삼치환 벤조트리아졸 유도체의 사용 방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1035188A (fr) * 1974-08-15 1978-07-25 Eastman Kodak Company Substances retardatrices de developpement partiel
US4273860A (en) * 1977-12-28 1981-06-16 Eastman Kodak Company Inhibition of image formation utilizing cobalt(III) complexes
CA1126999A (fr) 1978-10-20 1982-07-06 Michael J. Simons Utilisation de derives de l'azole a groupe carbomoyl disubstitue en n,n, sur de l'azote cyclique, comme precurseurs pour la retenue du developpement dans des elements photographiques
JPS6239573A (ja) * 1985-08-13 1987-02-20 Sumitomo Chem Co Ltd シクロアルケニルアミド誘導体、その製造法およびそれを有効成分とする土壌病害防除剤
US6372421B1 (en) * 2000-06-13 2002-04-16 Eastman Kodak Company Photothermographic imaging element having improved contrast and methods of image formation
US6440648B1 (en) * 2000-06-13 2002-08-27 Eastman Kodak Company Color photographic element having improved contrast and compatibility with both dry and conventional processing
CZ20032990A3 (cs) 2001-05-05 2004-04-14 Smithkline Beecham P. L. C. N-aroylové cyklické aminy
CA2468413A1 (fr) 2001-12-14 2003-06-26 Novo Nordisk A/S Composes ralentissant l'activite de la lipase hormono-sensible
DE10247680B4 (de) * 2002-10-12 2005-09-01 Aventis Pharma Deutschland Gmbh Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase
ATE442139T1 (de) * 2003-03-31 2009-09-15 Lilly Co Eli 3-oxo-1,3-dihydro-indazol-2-carbonsäureamid derivate als phospholipase inhibitoren

Also Published As

Publication number Publication date
BRPI0617613A2 (pt) 2011-08-02
WO2007045393A1 (fr) 2007-04-26
US20080287503A1 (en) 2008-11-20
IL190714A0 (en) 2008-11-03
RU2008119460A (ru) 2009-11-27
JP2009512650A (ja) 2009-03-26
GT200600463A (es) 2007-05-21
HN2006035238A (es) 2010-05-24
PE20070724A1 (es) 2007-08-07
NZ567573A (en) 2010-06-25
KR20080063474A (ko) 2008-07-04
DOP2006000226A (es) 2007-05-15
MA29858B1 (fr) 2008-10-03
CR9850A (es) 2008-06-18
RU2430096C2 (ru) 2011-09-27
TNSN08177A1 (en) 2009-10-30
US20110118321A1 (en) 2011-05-19
ZA200802370B (en) 2008-12-31
DE102005049953A1 (de) 2007-04-26
EP1940807B1 (fr) 2015-06-17
AU2006303552A1 (en) 2007-04-26
CN101291918A (zh) 2008-10-22
UY29872A1 (es) 2007-05-31
EP1940807A1 (fr) 2008-07-09
TW200730513A (en) 2007-08-16
CA2625722A1 (fr) 2007-04-26
US7897625B2 (en) 2011-03-01
AR057554A1 (es) 2007-12-05
ECSP088377A (es) 2008-05-30

Similar Documents

Publication Publication Date Title
NO20082159L (no) Triazolopyridinderivater som inhibitorer av lipaser og fosfolipaser
NO20084418L (no) Azolopyridin-3-on derivater som inhibitorer av endoteliallipase
NO20091409L (no) Pyridin-3-yl-derivater som immunmodulerende midler
NO20076648L (no) Novel thiophene derivatives
NO20063925L (no) Indazolderivater som inhibitorer av hormonsensitiv lipase
NO20083427L (no) Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
NO20091553L (no) Fenylderivater og deres anvendelse som immunmodulatorer
DK2324008T3 (da) Diarylpyrazol som protein kinase inhibitorer
NO20064599L (no) Substituerte morfolin- og tiomorfolinderivater
NO20090628L (no) Pyridizinon derivativater
NO20091395L (no) Nye tiofenderivater
NO20080675L (no) P38-Map kinaseinhibitorer og metoder for deres anvendelse
EA200970595A1 (ru) Производные замещенных индазолов, активные в качестве ингибиторов киназ
NO20071593L (no) Pyrimidinderivater
NO20074275L (no) 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister
NO20081315L (no) Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser
NO20074703L (no) Antibakterielle piperidinderivater
NO20083726L (no) Spiroindolinon derivater
NO20092476L (no) Antibakterielle polycykliske ureaforbindelser
NO20092737L (no) Substituerte pyrazolo-kinazolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som kinase-inhibitorer
SG148178A1 (en) Indozolone derivatives as 11b-hsd1 inhibitors
NO20054848L (no) Substituerte p-diaminobenzenderivater
NO20083058L (no) Cykloheksylsulfonamidderivater med H3 reseptor aktivitet
NO20080554L (no) Pyrazolonderivater
NO20080394L (no) N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application